Reducing Residual Vascular Risk Through combination Therapy with Fenofibrate and Alpha-Lipoic Acid in Patients with Ischemic Heart Disease and Type 2 Diabetes Mellitus
Loading...
Files
Date
Authors
Zhuravlyova, Larysa
Lopina, Nataliia
Journal Title
Journal ISSN
Volume Title
Publisher
Editor(s)
Abstract
To investigate effects of combination therapy with fenofibrate and α-lipoic acid on atherogenic dyslipidemia, which determines the residual vascular risk and endothelial dysfunction, levels of proinflammatory mediators in patients with ischemic heart disease and type 2 diabetes mellitus.
Description
Citation
Zhuravlyova L. Reducing Residual Vascular Risk Through combination Therapy with Fenofibrate and Alpha-Lipoic Acid in Patients with Ischemic Heart Disease and Type 2 Diabetes Mellitus : Abstracts from 15th International & 14th European Congress of Endocrinology, Florence, Italy, 5–9 May, 2012 / L. Zhuravlova, N. Lopina // Endocrine Abstracts. – 2012. – Vol. 29. – P. 713.